Boehringer Ingelheim won the lawsuit for Micardis Plus
Boehringer Ingelheim Korea won a lawsuit for the formulation patent of Micardis Plus against the Ministry of Food and Drug Safety.
The 6th Division of the Seoul Administrative Court has recently ordered the Ministry of Food and Drug Safety to withdraw the refusal to register the Boehringer Ingel...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
